Psychiatry

Acadia Pharmaceuticals has announced positive findings for time to psychosis relapse in dementia patients, which resulted in the trial's early end.

Recent research advances have associated the gut's health to overall patient health. What do we know now?

After success in multiple clinical trials, officials tout esketamine as a treatment for both major depressive disorder with active suicidal ideation and treatment resistant depression.

Investigators report positive results using esketamine spray to treat patients with major depressive disorder.

In a retrospective study using the data of 20,741 patients, investigators discover the primary cause of emergency department visits for geriatric patients is head trauma.

Investigators submit recommendations for physicians for Parkinson disease reflecting recent advancements, including a new section on palliative care.

A study of human gut bacteria suggests that high blood pressure with depression may be a completely different disease than high blood pressure without depression.

Benzodiazepines are a common yet not very well understood drug class for elderly patients with insomnia.

In a double-blind, phase 2 trial, investigators find that SAGE-17 results in a reduction of depressive symptoms after 2 weeks.

In honor of National Suicide Prevention Week, Simon Rego, PsyD, and colleagues from Montefiore will look at suicide from a public health and clinical scope.

In a new clinical trial, investigators found a FAAH inhibitor improves the recall of fear extinction memories while reducing the impact of stress in PTSD patients.

A new set of 22 recommendations include a combination of universal screenings, medication, and other preventative initiatives in an effort to drive down veteran suicide rates.

Despite a common belief that medications treating mental illnesses are connected to weight gain, new data shows an individual in a weight management program will lose weight whether or not they are taking antidepressants or antipsychotics.

How does the highly recommended practice benefit patients, and where are its gaps in care?

New data suggests that type 2 diabetes linked to PTSD are less likely to occur among patients with clinically meaningful PTSD symptom reduction through treatment or spontaneous improvement.

In a comprehensive new study, investigators discover unique patterns in the brains of both family members and patients with psychotic disorders, including bipolar disorder and schizophrenia.

How do physicians help manage their patient's sleep health for best outcomes?

A pattern of poor sleep could lead to worsened psychiatric wellbeing—and eventually, memory loss.

In a new study, investigators examine the efficacy and tolerability of antipsychotic medications for patients in remission for psychotic depression.

In a new population-based study, investigators discover sex differences in burdensome interventions and antibiotic therapy for nursing home residents with advanced dementia in Canada.

In an extensive population-based study, investigators link children with IBD with an increased risk of any psychiatric disorder.

The association of depression symptoms with cognition and cortical amyloid measurements could lead to better therapies to prevent Alzheimer disease.

A new study looks at the links between ADHD and bipolar disorder in children and adolescents.

In a new cohort study, investigators examine the link between blood pressure and cognitive decline.